GlassScriptPhysician profile
Joseph MD Kueter
NPI 1053383174
$21,103.79
in general payments reported to CMS, 2019-2025
31 companies · $399 in 2025
The $399 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,081 · 2020: $6,924 · 2021: $3,609 · 2022: $222 · 2023: $281 · 2024: $589 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,268.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ozark Cryosurgery, LLC | $18,312.00 | 2019-2021 | |
| Boston Scientific Corporation | $323.93 | 2019-2024 | Rezum Generator |
| Coloplast Corp | $311.78 | 2019-2025 | |
| Abbvie INC. | $297.62 | 2020-2025 | |
| Astellas Pharma US INC | $199.34 | 2019-2024 | Myrbetriq, Veozah |
| Intuitive Surgical, INC. | $166.07 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $139.32 | 2020-2025 | Prolaris |
| Medtronic, INC. | $127.10 | 2022-2025 | Altaviva, Interstim |
| Pfizer INC. | $119.80 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $110.75 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $105.99 | 2023-2025 | Orgovyx |
| Myovant Sciences INC. | $105.24 | 2021-2022 | |
| Blue Earth Diagnostics | $90.13 | 2019-2023 | |
| Procept Biorobotics Corporation | $79.10 | 2020-2023 | Aquabeam Robotic System |
| Baxter Healthcare | $78.12 | 2024 | Perclot |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Koelis INC. | $73.97 | 2024 | |
| Janssen Biotech, INC. | $64.84 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $49.71 | 2019 | |
| Conmed Corporation | $48.68 | 2025 | Airseal |
| Urogen Pharma, INC. | $44.99 | 2021-2022 | |
| Axonics, INC. | $44.29 | 2022 | |
| Medtronic USA, INC. | $40.44 | 2019-2020 | |
| Olympus America INC. | $32.30 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $24.05 | 2025 | |
| Allergan, INC. | $21.50 | 2021 | |
| Amgen INC. | $18.73 | 2020 | |
| Biocompatibles, INC. | $17.33 | 2019 | |
| Merck Sharp & Dohme LLC | $16.78 | 2020 | |
| Civco Medical Instruments | $15.74 | 2025 | |
| Angiodynamics, INC. | $13.16 | 2024 | Nanoknife |
| Endo Pharmaceuticals INC. | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$50,200.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Kueter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.